Company / Capital Expenditures
Disc Medicine, Inc. Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$933.0K
FY2025
5-year range
$68.0K / $933.0K
FY2021-FY2025
Trend
+84.8%
vs FY2024
Sector context
#116 of 194
Health Care
What the data says
At $933,000, Disc Medicine, Inc.'s capital expenditures ranks #116 of 194 in the Health Care sector. Improved from $89,000 to $933,000 over the past 2 years.
Based on SEC 10-K filings.
$933,000 in FY2025 with a 5-year CAGR of +111.6%.
Improved from $89,000 to $933,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +83.5%
- 5-Year CAGR
- +111.6%
- 10-Year CAGR
- -
Sector benchmark
#116 of 194 in Health CareTop 60% of 194This company $933.0K Sector average $117.5M
▼
-99.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +111.6%, indicating consistent growth.
- In FY2025, capital expenditures increased 84.8% year-over-year.
- Ranks #116 out of 194 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $933.0K | +84.8% |
| FY2024 | $505.0K | +467.4% |
| FY2023 | $89.0K | -41.1% |
| FY2022 | $151.0K | +122.1% |
| FY2021 | $68.0K | +209.1% |
| FY2020 | $22.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026